Coag vials & controls for coaguchek XS (POC)
Ended Purchase Order Awarded Last action
- Contract number
- 36C26220P1144
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Opportunity
-
- 6640--Coag vials & controls Solicitation · 36C26220Q0694 · Posted Apr 21, 2020
- Contract value 0% obligated
- $88,301.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92161, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $0 | |
| Funding Only Action | -$2,200 | |
| Exercise an Option | $23,161 | |
| Exercise an Option | $23,161 | |
| Funding Only Action | -$2,142 | |
| Exercise an Option | $23,161 | |
| Original award | $23,161 |
About this award
Roche Diagnostics Corporation was awarded a $88,301.80 firm fixed-price purchase order by Veterans Integrated Service Network 22 (VISN 22) on May 8, 2020, for coagulation vials and controls for the CoaguChek XS point-of-care testing system. The contract, which carries no set-aside designation, reflects open competition and was awarded rapidly following the solicitation posting on April 21, 2020, with a due date of April 29, 2020. Performance of the contract is based in San Diego, California, with an ultimate completion date of March 5, 2026.
This award supports VISN 22's clinical laboratory operations through the provision of essential coagulation testing supplies for point-of-care testing, enabling Veterans Affairs facilities to conduct rapid prothrombin time and international normalized ratio (PT/INR) assessments. Roche Diagnostics Corporation, a global leader in in vitro diagnostics headquartered in Indianapolis, Indiana, maintains an extensive federal contracting presence across the Department of Veterans Affairs and Defense Health Agency. The company holds multiple active indefinite delivery contracts and blanket purchase agreements with federal healthcare entities, including a $3.1 million BPA with VISN 22 for immunohistochemistry and in-situ hybridization equipment and services extending through September 2030, demonstrating a sustained procurement relationship with this Veterans Integrated Service Network.
Quick answers
Who was awarded contract 36C26220P1144?
36C26220P1144 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 22 (Veterans Health Administration) on May 8, 2020.
How much is contract 36C26220P1144 worth?
The government has obligated $0 on 36C26220P1144. Its current value, with exercised options, is $88,302.
Was contract 36C26220P1144 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award